Strategikon has rolled out a major update to its clinical trial management platform, focusing on improved vendor management capabilities. The new features aim to streamline operations, improve contract management, and increase transparency in managing multi-vendor clinical trials, enhancing collaboration across various stakeholders in clinical research.
“At Strategikon, our customers are at the heart of every innovation we bring to the VISION platform. With the release of VISION 4.3, we have listened to our users’ needs and delivered new tools that will empower them to manage their clinical trials more efficiently and effectively,” said Anca Copaescu, CEO, Strategikon. “Our goal is to simplify complex processes such as vendor evaluation, issue tracking, and compliance and category management, so our customers can focus on what truly matters—bringing life-saving therapies to patients faster.”
Discover more here.